Novavax Inc (NVAX)

EBITDA Growth

-141.49%

TTM · Period ending:

NVAX logo

NVAX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-141.49%
NVAX TTM EBITDA YoY % (8.33% → -141.49%)
High-resolution chart · PNG

NVAX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Novavax Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-52.6064%
-155.9226%
-189.2381%
-73.9375%
-51.7273%
3%
14.2857%
-11.6279%
-4.7619%
-16.6667%
-11.3636%
15.6863%
14.2857%
12.5%
8.3333%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.